Hans Hendrischke
Media playback is unsupported on your device

China's anti-corruption push continues

A British man and his American wife will face court in China next month in connection with bribery allegations involving the pharmaceutical giant GlaxoSmithKline.

The development makes up part of a broader anti-corruption push in China.

But how transparent are the processes involved in the anti-graft campaign and how will it affect other multinationals?

Hans Hendrischke, director of the China Studies Centre at The University of Sydney, says the Mainland's anti-corruption drive is simply a regular rotation of government processes which, in the end, will favour multinationals.

Watch more reports on Asia Business Report's website.

Go to next video: Glaxo 'paid Polish doctors bribes'